The other group at the highest risk when it comes to RSV is children under age five, and specifically infants—especially ...

Regarding hospitalizations among immunocompetent older adults, vaccine effectiveness was 83% for the GSK vaccine and 73% for ...

Current guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV)—which typically ...

The world's first bivalent mRNA vaccine candidate against respiratory syncytial virus, or RSV, kicked off Phase I clinical ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window In May, the FDA approved the mRNA-1345 RSV vaccine (mResvia) from Moderna for people ages 60 and older to protect ...

Current guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV)-;which typically causes mild, cold-like symptoms in most adults but can be deadly for ...

The seasonal COVID-19 spike, combined with rising cases of seasonal flu and RSV, brings what has been called a “tripledemic.” ...

The shift to a clear recommendation for vaccination goes beyond the prior guidance "just to encourage adults to talk to their ...

RSV, a potentially lethal lung infection ... The figures come as a new vaccine that could stop people from developing the vomiting bug norovirus is being trialled in the UK.

RSV, or respiratory syncytial virus ... The figures come as a new vaccine that could stop people from developing the vomiting bug norovirus is being trialled in the UK. The mRNA vaccine from ...

Respiratory syncytial virus (RSV) is the most important cause of infantile bronchiolitis and pneumonia. It is ubiquitous, with most children acquiring their primary infection within the first year ...

Cases of COVID-19 have waned in the weeks since the launch of the latest booster shot and the beginning of the academic school year. But, once again, COVID-19 isn’t the only respiratory infection ...